Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on CELH stock, giving a Buy rating yesterday.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anthony Vendetti has given his Buy rating due to a combination of factors that highlight Celsius Holdings’ strategic growth and market positioning. A significant factor is the expanded partnership with PepsiCo, which not only increases PepsiCo’s stake in Celsius to 11.3% but also integrates Alani Nu into PepsiCo’s distribution network. This partnership is expected to enhance Celsius’s market reach and growth potential, especially with the acquisition of Rockstar Energy, which adds to its portfolio and strengthens its presence in key markets.
Furthermore, the financial outlook for Celsius is promising, with increased revenue and earnings projections for the coming years. The company’s strategic moves, such as the transition of Alani Nu and the acquisition of Rockstar Energy, are anticipated to stabilize and grow its market share. The premium valuation of Celsius, justified by its projected growth rate surpassing that of its peers, supports the increased price target of $80. These elements collectively underpin Vendetti’s optimistic view and Buy rating on Celsius Holdings.
According to TipRanks, Vendetti is an analyst with an average return of -24.6% and a 26.46% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Icecure Medical, Daxor, and Rockwell Med.
In another report released yesterday, Stifel Nicolaus also maintained a Buy rating on the stock with a $70.00 price target.